For citations:
Muraviev YV, Gridneva GI, Muravieva LA, Muravieva NV, Alexeeva AV, Nurbaeva KS, Mikhailov KM, Rozov AV. Rationales for discontinuation of disease-modifying antirheumatic drugs, biologic agents, and tofacitinib in rheumatoid arthritis. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2018;12(4):101-105. (In Russ.) https://doi.org/10.14412/1996-7012-2018-4-101-105